Glycaemic benefit of iGlarLixi in insulin‐naive type 2 diabetes patients with high HbA1c or those with inadequate glycaemic control on two oral antihyperglycaemic drugs in the LixiLan‐O randomized trial
2019 ◽
Vol 21
(8)
◽
pp. 1967-1972
◽
Keyword(s):
2002 ◽
Vol 4
(3)
◽
pp. 177-186
◽
Keyword(s):
2016 ◽
Vol 42
(6)
◽
pp. 457-461
◽
Keyword(s):
2005 ◽
Vol 22
(10)
◽
pp. 1343-1346
◽
2012 ◽
Vol 38
(2)
◽
pp. 102-112
◽
2005 ◽
Vol 99
(3)
◽
pp. e63-e67
◽
Keyword(s):
2003 ◽
Vol 19
(6)
◽
pp. 541-545
◽
Keyword(s):
Keyword(s):